Orthopedic Implants Market Depth Analysis By Statistics, Industry Size Report 2020

1. Title : Global Orthopedic Implants Market to Register a CAGR of 4.1% till2026 Global Orthopedic Implants Market to Reach USD 64.0 Billion by2026 Description : Global Orthopedic Implants Market to Gain Traction; Siora Surgical Launches Its Range of Bone Implants, Helix Lock Plate Systems Product Line: Fortune Business Insights Content: The global orthopedic implants market sizeis set to touch USD 64.0 billion by 2026, exhibiting a modest CAGR of 4.1% during the forecast period. Unprecedented rise in geriatric population across the globe to be the key growth driver of this market.Accordingto the United States Census Bureau (USCB), the proportion of aged people to the total world population is steadily climbing. For example, in 2012, world population had reached 7 billion and the people aged 65 and above were 8% of this number or 562 million. In 2015, the number rose by 55 million, with the percentage increasing to 8.5% of the total population in a span of 3 years. The USCB predicts that between 2025 and 2050, this geriatric population will double to reach 1.6 billion, whilst the total population will grow only by34%. An Overview of the Impact of COVID-19 on thisMarket: The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses acrossindustries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by thepandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for thefuture. Click here to get the short-term and long-term impact of COVID-19 on this[Market]. For More Information : https://www.fortunebusinessinsights.com/industry-reports/orthopedic- implants-market-101659 Widespread Prevalence of Musculoskeletal Conditions to Spike MarketDemand Musculoskeletal conditions refer to disorders that adversely affect the locomotor system in the body, that is, bones, muscles, joints, ligaments, and tissues. Disorders related to these movements are increasing in prevalence, as stated by the World Health Organization (WHO). According to the WHO, between 20% and 33% of the world’s population is currently suffering from some painful and chronic musculoskeletal disease. The 2017 Global Burden of Disease Report revealed that musculoskeletal conditions were the second leading contributor to global disability, accounting for about 16% of all years with disability inan

2. individual’s life. Given the economic costs associated with these disorders, the need to prevent them is stronger than ever today, which augurs well for the market as it will spur innovation among players in the forecastperiod. North America to Hold a Commanding Position; Europe to Grow at an ImpressiveRate Among regions, North America is expected to dominate the global orthopedic implants market share owing to the increasing incidence of osteoarthritis in the region. Europe is projected to grow at a considerable rate on account of rapid spread of chronic diseases such as diabetes and obesity in the continent. In Asia-Pacific, rise in healthcare expenditure and increasing disposable incomes will propel the market in the region, as per the orthopedic implants market analysis by Fortune Business Insights. However, the market growth in Africa, Latin America, and the Middle East is anticipated to be slow due to low levels of development in theseregions. New Product Launches to Intensify MarketCompetition Key players are looking to gain an edge in the competition through development and launch of new products. For instance, in September 2019, Zimmer Biomet, after receiving FDA approval, commercially released its customizable revision knee replacement device called Persona Revision Knee System for patients in the US. Some other players are engaging in sprucing up their research capacities through commissioning of trials and studies. For example, in September 2019, Medtronic’s clinical trial for testing its spine correction surgical procedure, InfuseBone Graft in Transforaminal Lumbar Interbody Fusion (TLIF), was green lit by theFDA. More Trending Topics from Fortune Business Insights: Mobility Devices Market, Share, Growth, Sales and Drivers Analysis Research Report2026 Mobility Devices Market to Reach $14.86 Billion by 2026; Rising Incidence of Physical Disabilities Worldwide to Favor Growth of the Market: Fortune BusinessInsights™